Clinical Trial Update: Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM). [Phase 1, Phase 2]

View source ↗

Summary

Status update on a Phase 1/Phase 2 trial evaluating dapagliflozin in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Amira Bisher,PhD | Conditions: Diabetes Mellitus, Non Alcholic Fatty Liver Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING